TLR4 and cancer: al. (2016) reported that inhibition of TLR4 signaling via a blocking antibody significantly reduced the number of PD-1+ B cells in human hepatoma tissues, where PD-1+ B cell populations promoted cancer growth (Xiao et al. 2016).